Nasus Pharma Ltd (NSRX)

Nasus Pharma Ltd experienced multiple purchase transactions by Chief Executive Officer Teleman Dan Benjamin throughout the spring of 2026. The most recent activity occurred on June 17, 2026, involving the acquisition of 6,550 shares. These consistent buying patterns represent the primary insider trading activity recorded for the firm during this period.
Ticker: NSRX Exchange: ASE


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nasus Pharma Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
261.11
Quantity 15,170 -3.7%
Value US$4,119,075
3.4
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
177.62
Quantity 61,381 +42.8%
Value US$3,174,867
3.4
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
252.02
Quantity 63,507 -18.0%
Value US$3,175,342
3.4
Teleman Dan Benjamin Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.04
Quantity 15,000 +240.2%
Value US$30,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-22 2026-06-17 B Purchase

Chief Executive Officer

Executive Director
15,170 -3.7%
261.11
US$4,119,075
15,170 -3.7% 261.11 US$4,119,075
2026-06-22 2026-06-17 B Purchase

Chief Executive Officer

Executive Director
61,381 +42.8%
177.62
US$3,174,867
61,381 +42.8% 177.62 US$3,174,867
2026-04-22 2026-04-22 B Purchase

Chief Executive Officer

Executive Director
63,507 -18.0%
252.02
US$3,175,342
63,507 -18.0% 252.02 US$3,175,342
2026-04-01 2026-03-31 B Purchase

Chief Executive Officer

Executive Director
15,000 +240.2%
2.04
US$30,600
15,000 +240.2% 2.04 US$30,600